Skip to main content

RETRACTED: Aging-associated distinctive DNA methylation changes of LINE-1 retrotransposons in pure cell-free DNA from human blood.

Mahmood W, Erichsen L, Ott P, Schulz WA, Fischer JC, Arauzo-Bravo MJ, Bendhack ML, Hassan M, Santourlidis S

Publication: Sci Rep (2020) • Vol 10 • Page 22127PMID: 33335196View on PubMed

Purpose

The Publisher’s Retraction Note can be found at https://www.nature.com/articles/s41598-022-07275-4.

This paper investigated the effects of patient age and gender on Long Interspersed Nuclear Element-1 (LINE-1) methylation in cellular DNA and cell-free DNA (cfDNA) and on levels of LINE-1 ORF1 protein. A comparison of extraction kits used for the isolation of cfDNA from plasma was also performed.

Conclusion

Only extraction with QIAamp MinElute ccfDNA Kit yielded cfDNA without genomic contamination as detected by ethidium bromide stained gels. While Line-1 methylation in cellular DNA was unaffected by patient age, a weak negative correlation was found between patient age and LINE-1 methylation of cfDNA (R2=0.31) by methylation-specific PCR with significantly lower LINE-1 methylation of cfDNA observed in patients aged 31-40 years, 41-50 years, and 51-60 years compared to patients aged 19-30 years and patients aged 51-60 years versus 31-40 years. Although LINE-1 methylation of cellular DNA was higher in females than males aged 19-40 and higher in males than females aged 41-50, cfDNA LINE-1 methylation tended to be non-significantly lower in females than males aged 19-50. Methylation-specific sequencing identified higher methylation of cellular DNA and cfDNA from patients aged 21-29 years than patients aged 50-58 years but the differences were more pronounced in cfDNA. Interestingly, ELISA showed comparable levels of the LINE-1 ORF1 product in young and old patients.

Studies (1)

Purpose

The Publisher’s Retraction Note can be found at https://www.nature.com/articles/s41598-022-07275-4.

This study investigated the effects of patient age and gender on LINE-1 methylation in cellular DNA and cfDNA and on levels of LINE-1 ORF1 protein. A comparison of extraction kits used for the isolation of cfDNA from plasma was also performed. EDTA blood was collected from 97 healthy donors aged 19-73 years (46 males, 51 females). Blood was centrifuged at 3600 rpm for 10 min and the resultant buffy coat and plasma were stored at -20°C. Cellular DNA was isolated from the buffy coat using the QiAamp DNA Blood Mini Kit and cfDNA was isolated from plasma using the using the QiAamp DNA Blood Mini, PME free-circulating DNA Extraction, Quick-cfDNA Serum & Plasma, and QIAamp MinElute ccfDNA kits. The isolation of cfDNA in the absence of genomic DNA was confirmed by electrophoresis. cfDNA isolated using QIAamp MinElute ccfDNA Kits was subjected to bisulfite conversion using the EpiTectBisulfite Kit. LINE-1 methylation was quantified by methylation-specific real-time PCR amplification of cellular and cfDNA which was normalized by real-time PCR of an unmethylated neighboring region. cfDNA from eight patients aged 21-29 years and eight patients aged 50-58 years was excised from agarose gels, bisulfite converted, amplified, TA cloned using the Invitrogen TA Cloning Kit, and sequenced using BigDye Terminator Cycle Sequencing Kit. Levels of ORF1 protein were quantified by ELISA in the plasma of three young (19-23 years) and three older (58-73 years) patients.

Summary of Findings

Only extraction with QIAamp MinElute ccfDNA Kit yielded cfDNA without genomic contamination as detected by ethidium bromide stained gels. While Line-1 methylation in cellular DNA was unaffected by patient age, a weak negative correlation was found between patient age and LINE-1 methylation of cfDNA (R2=0.31) by methylation-specific PCR. When patients were stratified by age, significantly lower LINE-1 methylation of cfDNA was observed in patients aged 31-40 years, 41-50 years, and 51-60 years compared to patients aged 19-30 years (P=0.01, P=0.0000043, and P= 0.0000000049; respectively) and in patients aged 51-60 years versus 31-40 years (P=0.0041). Although LINE-1 methylation of cellular DNA was higher in females than males aged 19-40 but higher in males than females aged 41-50 (P value not stated), cfDNA LINE-1 methylation tended to be non-significantly lower in females than males aged 19-50.  Methylation-specific sequencing identified higher methylation of cellular DNA and cfDNA from patients aged 21-29 years than patients aged 50-58 years but the differences were more pronounced in cfDNA (62% versus 50% and 68% versus 20%, respectively). The elements most likely to be differentially methylated in cfDNA of old (50-58 years) versus young (21-29 years) patients were located at CpG positions -29, -27, -23, -20, -17, -14, and -13. Interestingly, ELISA showed comparable levels of the LINE-1 ORF1 product in young and old patients.

  • Biospecimens

    FluidBlood
    FluidBuffy Coat
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    DNAElectrophoresis
    DNABisulfite conversion assay
    DNADNA sequencing
    DNAReal-time qPCR
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPatient age
    19-30 years
    19-73 years
    31-40 years
    41-50 years
    51-60 years
    PreaquisitionPatient gender
    Female
    Male
    Analyte Extraction and PurificationAnalyte isolation method
    QIAamp MinElute ccfDNA Kit
    QiAamp DNA Blood Mini Kit
    Quick-cfDNA Serum & Plasma Kit
    cfDNA by PME free-circulating DNA Extraction Kit
    Bisulfite conversion assay SpecificTargeted nucleic acid
    LINE-1 promoter
    Bisulfite conversion assay SpecificTechnology platform
    Bisulfite genomic sequencing
    Methylation-specific PCR